Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Leukemia Research, Verlag: Elsevier, Erscheinungsjahr: 2018, Jahrgang: 69, Heft: 6
- Event
-
Veröffentlichung
- (where)
-
Leipzig
- (who)
-
Universitätsbibliothek Leipzig
- (when)
-
2020
- Creator
-
Grohmann, Theresa
Penke, Melanie
Petzold-Quinque, Stefanie
Schuster, Susanne
Richter, Sandy
Kiess, Wieland
Garten, Antje
- URN
-
urn:nbn:de:bsz:15-qucosa2-385901
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grohmann, Theresa
- Penke, Melanie
- Petzold-Quinque, Stefanie
- Schuster, Susanne
- Richter, Sandy
- Kiess, Wieland
- Garten, Antje
- Universitätsbibliothek Leipzig
Time of origin
- 2020
Other Objects (12)
The C. elegans p53 pathway
The C. elegans p53 pathway
The p53 network in chronic lymphocytic leukemia
Investigation of the ATM/p53 signaling pathway in primary leukemic B cells isolated from patients with chronic lymphocytic leukemia
X-Ray Treatment of Chronic Leukemia
Current treatment of juvenile myelomonocytic leukemia
Treatment-free remission in chronic myeloid leukemia
Optimal programs of pathway control: dissecting the influence of pathway topology and feedback inhibition on pathway regulation
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
Model-based optimal treatment schedules for acute leukemia
The C. elegans p53 pathway
The C. elegans p53 pathway
The p53 network in chronic lymphocytic leukemia
Investigation of the ATM/p53 signaling pathway in primary leukemic B cells isolated from patients with chronic lymphocytic leukemia
X-Ray Treatment of Chronic Leukemia
Current treatment of juvenile myelomonocytic leukemia
Treatment-free remission in chronic myeloid leukemia
Optimal programs of pathway control: dissecting the influence of pathway topology and feedback inhibition on pathway regulation
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
Model-based optimal treatment schedules for acute leukemia
The C. elegans p53 pathway
The C. elegans p53 pathway
The p53 network in chronic lymphocytic leukemia
Investigation of the ATM/p53 signaling pathway in primary leukemic B cells isolated from patients with chronic lymphocytic leukemia
X-Ray Treatment of Chronic Leukemia
Current treatment of juvenile myelomonocytic leukemia
Treatment-free remission in chronic myeloid leukemia
Optimal programs of pathway control: dissecting the influence of pathway topology and feedback inhibition on pathway regulation
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia